 | • レポートコード：20QY06-07996 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、日本脳炎（JE）ワクチンのグローバル市場について種類別（不活化ワクチン、弱毒生ワクチン）、用途別（公用、個人用）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・日本脳炎（JE）ワクチン市場の概要 ・世界の主要地域別日本脳炎（JE）ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の日本脳炎（JE）ワクチン市場規模2015-2026：種類別（不活化ワクチン、弱毒生ワクチン） ・世界の日本脳炎（JE）ワクチン市場規模2015-2026：用途別（公用、個人用） ・日本脳炎（JE）ワクチンの北米市場規模2015-2020 ・日本脳炎（JE）ワクチンのヨーロッパ市場規模2015-2020 ・日本脳炎（JE）ワクチンの中国市場規模2015-2020 ・日本脳炎（JE）ワクチンの日本市場規模2015-2020 ・日本脳炎（JE）ワクチンの東南アジア市場規模2015-2020 ・日本脳炎（JE）ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GSK、Sanofi、Chengdu institute of biologica、Wuhan Institute of Biological、Lanzhou Institute of Biological、Beijing Taitan、Valneva、Bharat Biotech、Biological E. Limited、Liaoning Chengda） ・日本脳炎（JE）ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・日本脳炎（JE）ワクチンの市場動向・機会・課題 ・調査の結論 |
Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.
It is recommended as part of routine immunizations in countries where the disease is a problem. One or two doses are given depending on the version of the vaccine. Extra doses are not typically needed in areas where the disease is common. In those with HIV/AIDS or those who are pregnant an inactivated vaccine should be used. Immunization of travellers who plan to spend time outdoors in areas where the disease is common is recommended.
Market Analysis and Insights: Global Japanese Encephalitis (JE) Vaccine Market
The global Japanese Encephalitis (JE) Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Japanese Encephalitis (JE) Vaccine Scope and Market Size
The global Japanese Encephalitis (JE) Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Japanese Encephalitis (JE) Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Japanese Encephalitis (JE) Vaccine market is segmented into
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application, the Japanese Encephalitis (JE) Vaccine market is segmented into
Public
Private
The Japanese Encephalitis (JE) Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Japanese Encephalitis (JE) Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Japanese Encephalitis (JE) Vaccine Market Share Analysis
Japanese Encephalitis (JE) Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Japanese Encephalitis (JE) Vaccine business, the date to enter into the Japanese Encephalitis (JE) Vaccine market, Japanese Encephalitis (JE) Vaccine product introduction, recent developments, etc.
The major vendors covered:
GSK
Sanofi
Chengdu institute of biologica
Wuhan Institute of Biological
Lanzhou Institute of Biological
Beijing Taitan
Valneva
Bharat Biotech
Biological E. Limited
Liaoning Chengda
Table of Contents
1 Japanese Encephalitis (JE) Vaccine Market Overview
1.1 Japanese Encephalitis (JE) Vaccine Product Scope
1.2 Japanese Encephalitis (JE) Vaccine Segment by Type
1.2.1 Global Japanese Encephalitis (JE) Vaccine Sales by Type (2020-2026)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Japanese Encephalitis (JE) Vaccine Segment by Application
1.3.1 Global Japanese Encephalitis (JE) Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Public
1.3.3 Private
1.4 Japanese Encephalitis (JE) Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Japanese Encephalitis (JE) Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Japanese Encephalitis (JE) Vaccine Price Trends (2015-2026)
2 Japanese Encephalitis (JE) Vaccine Estimate and Forecast by Region
2.1 Global Japanese Encephalitis (JE) Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Japanese Encephalitis (JE) Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Japanese Encephalitis (JE) Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Japanese Encephalitis (JE) Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Japanese Encephalitis (JE) Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Japanese Encephalitis (JE) Vaccine Estimates and Projections (2015-2026)
2.4.3 China Japanese Encephalitis (JE) Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Japanese Encephalitis (JE) Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Japanese Encephalitis (JE) Vaccine Estimates and Projections (2015-2026)
2.4.6 India Japanese Encephalitis (JE) Vaccine Estimates and Projections (2015-2026)
3 Global Japanese Encephalitis (JE) Vaccine Competition Landscape by Players
3.1 Global Top Japanese Encephalitis (JE) Vaccine Players by Sales (2015-2020)
3.2 Global Top Japanese Encephalitis (JE) Vaccine Players by Revenue (2015-2020)
3.3 Global Japanese Encephalitis (JE) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Japanese Encephalitis (JE) Vaccine as of 2019)
3.4 Global Japanese Encephalitis (JE) Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Japanese Encephalitis (JE) Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Japanese Encephalitis (JE) Vaccine Players (Opinion Leaders)
4 Global Japanese Encephalitis (JE) Vaccine Market Size by Type
4.1 Global Japanese Encephalitis (JE) Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Japanese Encephalitis (JE) Vaccine Price by Type (2014-2020)
4.2 Global Japanese Encephalitis (JE) Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Japanese Encephalitis (JE) Vaccine Price Forecast by Type (2021-2026)
5 Global Japanese Encephalitis (JE) Vaccine Market Size by Application
5.1 Global Japanese Encephalitis (JE) Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Japanese Encephalitis (JE) Vaccine Price by Application (2015-2020)
5.2 Global Japanese Encephalitis (JE) Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Japanese Encephalitis (JE) Vaccine Price Forecast by Application (2021-2026)
3 North America Japanese Encephalitis (JE) Vaccine Market Facts & Figures
3.2 North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
4 Europe Japanese Encephalitis (JE) Vaccine Market Facts & Figures
4.2 Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
5 China Japanese Encephalitis (JE) Vaccine Market Facts & Figures
5.2 China Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
5.3 China Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
5.4 China Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
6 Japan Japanese Encephalitis (JE) Vaccine Market Facts & Figures
6.2 Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Japanese Encephalitis (JE) Vaccine Market Facts & Figures
7.2 Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
8 India Japanese Encephalitis (JE) Vaccine Market Facts & Figures
8.2 India Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
8.3 India Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
8.4 India Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Japanese Encephalitis (JE) Vaccine Business
12.1 GSK
12.1.1 GSK Japanese Encephalitis (JE) Vaccine Corporation Information
12.1.2 GSK Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.1.3 GSK Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Japanese Encephalitis (JE) Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi
12.2.1 Sanofi Japanese Encephalitis (JE) Vaccine Corporation Information
12.2.2 Sanofi Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.2.3 Sanofi Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Japanese Encephalitis (JE) Vaccine Products Offered
12.2.5 Sanofi Recent Development
12.3 Chengdu institute of biologica
12.3.1 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Corporation Information
12.3.2 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.3.3 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Products Offered
12.3.5 Chengdu institute of biologica Recent Development
12.4 Wuhan Institute of Biological
12.4.1 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Corporation Information
12.4.2 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.4.3 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Products Offered
12.4.5 Wuhan Institute of Biological Recent Development
12.5 Lanzhou Institute of Biological
12.5.1 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Corporation Information
12.5.2 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.5.3 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Products Offered
12.5.5 Lanzhou Institute of Biological Recent Development
12.6 Beijing Taitan
12.6.1 Beijing Taitan Japanese Encephalitis (JE) Vaccine Corporation Information
12.6.2 Beijing Taitan Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.6.3 Beijing Taitan Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Beijing Taitan Japanese Encephalitis (JE) Vaccine Products Offered
12.6.5 Beijing Taitan Recent Development
12.7 Valneva
12.7.1 Valneva Japanese Encephalitis (JE) Vaccine Corporation Information
12.7.2 Valneva Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.7.3 Valneva Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Valneva Japanese Encephalitis (JE) Vaccine Products Offered
12.7.5 Valneva Recent Development
12.8 Bharat Biotech
12.8.1 Bharat Biotech Japanese Encephalitis (JE) Vaccine Corporation Information
12.8.2 Bharat Biotech Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.8.3 Bharat Biotech Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bharat Biotech Japanese Encephalitis (JE) Vaccine Products Offered
12.8.5 Bharat Biotech Recent Development
12.9 Biological E. Limited
12.9.1 Biological E. Limited Japanese Encephalitis (JE) Vaccine Corporation Information
12.9.2 Biological E. Limited Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.9.3 Biological E. Limited Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biological E. Limited Japanese Encephalitis (JE) Vaccine Products Offered
12.9.5 Biological E. Limited Recent Development
12.10 Liaoning Chengda
12.10.1 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Corporation Information
12.10.2 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Business Overview and Total Revenue
12.10.3 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Products Offered
12.10.5 Liaoning Chengda Recent Development
13 Japanese Encephalitis (JE) Vaccine Manufacturing Cost Analysis
13.1 Japanese Encephalitis (JE) Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Japanese Encephalitis (JE) Vaccine
13.4 Japanese Encephalitis (JE) Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Japanese Encephalitis (JE) Vaccine Distributors List
14.3 Japanese Encephalitis (JE) Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Japanese Encephalitis (JE) Vaccine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Japanese Encephalitis (JE) Vaccine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. Global Market Japanese Encephalitis (JE) Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Region (2015-2020)
Table 5. Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Japanese Encephalitis (JE) Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Japanese Encephalitis (JE) Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Japanese Encephalitis (JE) Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Japanese Encephalitis (JE) Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Japanese Encephalitis (JE) Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Japanese Encephalitis (JE) Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Japanese Encephalitis (JE) Vaccine (K Doses) of Key Companies (2015-2020)
Table 13. Global Japanese Encephalitis (JE) Vaccine Sales Share by Company (2015-2020)
Table 14. Global Japanese Encephalitis (JE) Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Japanese Encephalitis (JE) Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Japanese Encephalitis (JE) Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Japanese Encephalitis (JE) Vaccine as of 2019)
Table 17. Global Japanese Encephalitis (JE) Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Japanese Encephalitis (JE) Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Japanese Encephalitis (JE) Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Japanese Encephalitis (JE) Vaccine Players
Table 22. Global Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Type (2015-2020)
Table 23. Global Japanese Encephalitis (JE) Vaccine Sales Share by Type (2015-2020)
Table 24. Global Japanese Encephalitis (JE) Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Japanese Encephalitis (JE) Vaccine Price (K Doses) by Type (2015-2020)
Table 26. Global Japanese Encephalitis (JE) Vaccine Sales Share by Type (2021-2026)
Table 27. Global Japanese Encephalitis (JE) Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Japanese Encephalitis (JE) Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Japanese Encephalitis (JE) Vaccine Price (K Doses) by Type (2021-2026)
Table 30. Global Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Application (2015-2020)
Table 31. Global Japanese Encephalitis (JE) Vaccine Sales Share by Application (2015-2020)
Table 32. Global Japanese Encephalitis (JE) Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Japanese Encephalitis (JE) Vaccine Price (K Doses) by Application (2015-2020)
Table 34. Global Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Application (2021-2026)
Table 35. Global Japanese Encephalitis (JE) Vaccine Sales Share by Application (2021-2026)
Table 36. Global Japanese Encephalitis (JE) Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Japanese Encephalitis (JE) Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Japanese Encephalitis (JE) Vaccine Price (K Doses) by Application (2021-2026)
Table 39. United States Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Company (2015-2020)
Table 40. United States Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Type (2015-2020)
Table 42. United States Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Application (2015-2020)
Table 44. United States Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Company (2015-2020)
Table 46. Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Type (2015-2020)
Table 48. Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Application (2015-2020)
Table 50. Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Company (2015-2020)
Table 52. China Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Type (2015-2020)
Table 54. China Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Application (2015-2020)
Table 56. China Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Company (2015-2020)
Table 58. Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Type (2015-2020)
Table 60. Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Application (2015-2020)
Table 62. Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Company (2015-2020)
Table 70. India Japanese Encephalitis (JE) Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Type (2015-2020)
Table 72. India Japanese Encephalitis (JE) Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Japanese Encephalitis (JE) Vaccine Sales (K Doses) by Application (2015-2020)
Table 74. India Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. GSK Japanese Encephalitis (JE) Vaccine Product
Table 79. GSK Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Sanofi Japanese Encephalitis (JE) Vaccine Product
Table 84. Sanofi Recent Development
Table 85. Chengdu institute of biologica Corporation Information
Table 86. Chengdu institute of biologica Description and Business Overview
Table 87. Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Product
Table 89. Chengdu institute of biologica Recent Development
Table 90. Wuhan Institute of Biological Corporation Information
Table 91. Wuhan Institute of Biological Description and Business Overview
Table 92. Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Product
Table 94. Wuhan Institute of Biological Recent Development
Table 95. Lanzhou Institute of Biological Corporation Information
Table 96. Lanzhou Institute of Biological Description and Business Overview
Table 97. Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Product
Table 99. Lanzhou Institute of Biological Recent Development
Table 100. Beijing Taitan Corporation Information
Table 101. Beijing Taitan Description and Business Overview
Table 102. Beijing Taitan Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Beijing Taitan Japanese Encephalitis (JE) Vaccine Product
Table 104. Beijing Taitan Recent Development
Table 105. Valneva Corporation Information
Table 106. Valneva Description and Business Overview
Table 107. Valneva Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Valneva Japanese Encephalitis (JE) Vaccine Product
Table 109. Valneva Recent Development
Table 110. Bharat Biotech Corporation Information
Table 111. Bharat Biotech Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Bharat Biotech Description and Business Overview
Table 113. Bharat Biotech Japanese Encephalitis (JE) Vaccine Product
Table 114. Bharat Biotech Recent Development
Table 115. Biological E. Limited Corporation Information
Table 116. Biological E. Limited Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Biological E. Limited Description and Business Overview
Table 118. Biological E. Limited Japanese Encephalitis (JE) Vaccine Product
Table 119. Biological E. Limited Recent Development
Table 120. Liaoning Chengda Corporation Information
Table 121. Liaoning Chengda Description and Business Overview
Table 122. Liaoning Chengda Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Liaoning Chengda Japanese Encephalitis (JE) Vaccine Product
Table 124. Liaoning Chengda Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Japanese Encephalitis (JE) Vaccine Distributors List
Table 128. Japanese Encephalitis (JE) Vaccine Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Japanese Encephalitis (JE) Vaccine Product Picture
Figure 2. Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Japanese Encephalitis (JE) Vaccine Market Share by Application in 2020 & 2026
Figure 6. Public Examples
Figure 7. Private Examples
Figure 8. Global Japanese Encephalitis (JE) Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Japanese Encephalitis (JE) Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Japanese Encephalitis (JE) Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Japanese Encephalitis (JE) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Japanese Encephalitis (JE) Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Japanese Encephalitis (JE) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Japanese Encephalitis (JE) Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Japanese Encephalitis (JE) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Japanese Encephalitis (JE) Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Japanese Encephalitis (JE) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Japanese Encephalitis (JE) Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Japanese Encephalitis (JE) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Japanese Encephalitis (JE) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Japanese Encephalitis (JE) Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Japanese Encephalitis (JE) Vaccine Players Market Share by Revenue in Japanese Encephalitis (JE) Vaccine 2015 & 2019
Figure 26. Japanese Encephalitis (JE) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Japanese Encephalitis (JE) Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Japanese Encephalitis (JE) Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Japanese Encephalitis (JE) Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Japanese Encephalitis (JE) Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Japanese Encephalitis (JE) Vaccine Sales Market Share by Type in 2019
Figure 32. United States Japanese Encephalitis (JE) Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Application in 2019
Figure 36. China Japanese Encephalitis (JE) Vaccine Sales Market Share by Company in 2019
Figure 37. China Japanese Encephalitis (JE) Vaccine Sales Market Share by Type in 2019
Figure 38. China Japanese Encephalitis (JE) Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Japanese Encephalitis (JE) Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Market Share by Application in 2019
Figure 45. India Japanese Encephalitis (JE) Vaccine Sales Market Share by Company in 2019
Figure 46. India Japanese Encephalitis (JE) Vaccine Sales Market Share by Type in 2019
Figure 47. India Japanese Encephalitis (JE) Vaccine Sales Market Share by Application in 2019
Figure 48. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Chengdu institute of biologica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Wuhan Institute of Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Lanzhou Institute of Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Beijing Taitan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bharat Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biological E. Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Liaoning Chengda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Japanese Encephalitis (JE) Vaccine
Figure 60. Manufacturing Process Analysis of Japanese Encephalitis (JE) Vaccine
Figure 61. Japanese Encephalitis (JE) Vaccine Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
日本脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Japanese Encephalitis (JE) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Japanese E…- 脳炎ワクチンの世界市場レポート2020 Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds. It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easi…
- 脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Encephalitis Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1461.8 million by 2025, from USD 1186.3 million in 2019. The Encephalitis Va…
- ライム病ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Lyme Disease Vaccine Market The global Lyme Disease Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Lyme Disease Vaccine Scope and Market Size The global Lyme …
- 弱毒生ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Live Attenuated Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Live Attenuated Vacci…